Hepatic lipogenesis increases FGF21 in children/adolescents with obesity

被引:0
|
作者
Maffeis, Claudio [1 ]
Morandi, Anita [1 ]
Zusi, Chiara [1 ]
Olivieri, Francesca [2 ]
Fornari, Elena [2 ]
Corradi, Massimiliano [1 ]
Emiliani, Federica [2 ]
Da Ros, Alessandro [1 ]
Mantovani, Alessandro [1 ]
Targher, Giovanni [1 ]
机构
[1] Univ Verona, Verona, Italy
[2] Univ Hosp Verona, Verona, Italy
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
RFC11.5
引用
收藏
页码:124 / 125
页数:2
相关论文
共 50 条
  • [41] An Overview of FGF19 and FGF21: The Therapeutic Role in the Treatment of the Metabolic Disorders and Obesity
    Babaknejad, Nasim
    Nayeri, Hashem
    Hemmati, Roohullah
    Bahrami, Somaye
    Esmaillzadeh, Ahmad
    HORMONE AND METABOLIC RESEARCH, 2018, 50 (06) : 441 - 452
  • [42] FGF21 ACEs hypertension
    Grant Otto
    Nature Reviews Nephrology, 2018, 14 : 413 - 413
  • [43] Mechanism for the effects of FGF21
    Claire Greenhill
    Nature Reviews Endocrinology, 2020, 16 : 472 - 472
  • [44] FGF21 action in the fat
    Randy Levinson
    Nature Medicine, 2012, 18 (3) : 360 - 361
  • [45] Metabolic Messengers: FGF21
    Flippo, Kyle H.
    Potthoff, Matthew J.
    NATURE METABOLISM, 2021, 3 (03) : 309 - 317
  • [46] FGF21 AS A THERAPEUTIC REAGENT
    Zhao, Yang
    Dunbar, James D.
    Kharitonenkov, Alexei
    ENDOCRINE FGFS AND KLOTHOS, 2012, 728 : 214 - 228
  • [47] Metabolic Messengers: FGF21
    Kyle H. Flippo
    Matthew J. Potthoff
    Nature Metabolism, 2021, 3 : 309 - 317
  • [48] Understanding the Physiology of FGF21
    Fisher, Ffolliott Martin
    Maratos-Flier, Eleftheria
    ANNUAL REVIEW OF PHYSIOLOGY, VOL 78, 2016, 78 : 223 - 241
  • [49] FGF21 and cardiac physiopathology
    Planavila, Anna
    Redondo-Angulo, Ibon
    Villarroya, Francesc
    FRONTIERS IN ENDOCRINOLOGY, 2015, 6
  • [50] Camel FGF21 Protein Enhances FGF21 Signaling and its Targeted Compounds Screening
    Gao, Yuan
    Yong, Fang
    Ji, Wangye
    Zhang, Lili
    Hou, Jibao
    Ma, Ruilin
    Zhao, Shuqin
    Ge, Huizhen
    Wu, Xiaoyu
    CURRENT PHARMACEUTICAL DESIGN, 2024,